Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?Roberto Russo, Aurora Parodi, Niccolò Capurro et al.|Journal of Clinical Medicine|2022Cited by 31
Guselkumab‐associated bullous pemphigoid in a psoriasis patient: A case report and review of the literatureMartina Burlando, Aurora Parodi, Niccolò Capurro et al.|Dermatologic Therapy|2021Cited by 21
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseasesNiccolò Capurro, Aurora Parodi, Vito Paolo Pastore et al.|British Journal of Dermatology|2024Cited by 17
Self‐resolving bullous pemphigoid induced by cemiplimabMattia Fabio Molle, Aurora Parodi, Niccolò Capurro et al.|Dermatologic Therapy|2022Cited by 6
Incorporating Diagnostic Prior with Segmentation: A Deep Learning Pipeline for the Automatic Classification of Autoimmune Bullous Skin DiseasesVito Paolo Pastore, Francesca Odone, Larbi Touijer et al.|Unknown|2023Cited by 4